Jeffrey A Meckler insider trades: Travere Therapeutics (TVTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | TVTX | ↓ Sell | 20,000 | $67.31 | $1.3M | Direct | Sep 11, 2026 (1d) |
| May 4, 2026 | TVTX | ↓ Sell | 8,000 | $45.00 | $360K | Direct | May 6, 2026 (2d) |
| Sep 30, 2024 | TVTX | ↓ Sell | 40,000 | $14.06 | $562K | Direct | Sep 30, 2024 (0d) |
| Nov 21, 2022 | INDP | ↑ Buy | 10,000 | $1.89 | $19K | Direct | Nov 22, 2022 (1d) |
| Sep 8, 2022 | INDP | ↑ Buy | 10,308 | $2.80 | $29K | Direct | Sep 12, 2022 (4d) |
| Sep 7, 2022 | INDP | ↑ Buy | 9,692 | $2.56 | $25K | Direct | Sep 8, 2022 (1d) |
| Jun 6, 2022 | INDP | ↑ Buy | 19,727 | $2.63 | $52K | Direct | Jun 7, 2022 (1d) |
| Nov 18, 2021 | INDP | ↑ Buy | 11,187 | $5.82 | $65K | Direct | Nov 19, 2021 (1d) |
| Sep 14, 2021 | INDP | ↑ Buy | 12,000 | $7.00 | $84K | Direct | Sep 16, 2021 (2d) |
| Aug 28, 2019 | NTEC | ↑ Buy | 20,000 | $0.68 | $14K | Direct | Aug 29, 2019 (1d) |
| Aug 23, 2019 | NTEC | ↑ Buy | 100,000 | $0.46 | $46K | Direct | Aug 27, 2019 (4d) |
| Mar 15, 2016 | COCP | ↑ Buy | 294,118 | $0.51 | $150K | Direct | Mar 17, 2016 (2d) |
| Mar 4, 2016 | RTRX | ↑ Buy | 5,000 | $15.31 | $77K | Direct | Mar 7, 2016 (3d) |
| Mar 3, 2016 | RTRX | ↑ Buy | 10,000 | $14.45 | $145K | Direct | Mar 3, 2016 (0d) |
| Dec 23, 2015 | COCP | ↑ Buy | 100,000 | $0.58 | $58K | Direct | Dec 28, 2015 (5d) |
| Mar 25, 2015 | COCP | ↑ Buy | 163,043 | $0.92 | $150K | Direct | Mar 27, 2015 (2d) |
| Dec 18, 2014 | QLTI | ↑ Buy | 20,000 | $3.60 | $72K | Direct | Dec 19, 2014 (1d) |
| Dec 11, 2014 | COCP | ↑ Buy | 100,000 | $0.46 | $46K | Direct | Dec 15, 2014 (4d) |
| Nov 25, 2014 | RTRX | ↑ Buy | 15,000 | $8.60 | $129K | Direct | Nov 25, 2014 (0d) |
| Jun 28, 2013 | QLTI | ↑ Buy | 30,000 | $4.36 | $131K | Direct | Jul 1, 2013 (3d) |
| May 3, 2013 | QLTI | ↑ Buy | 20,000 | $7.96 | $159K | Direct | May 6, 2013 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TVTX insiders
Open-market trades in the last 12 months
About Jeffrey A Meckler's insider trades
Jeffrey A Meckler is an insider at Travere Therapeutics (TVTX). Since May 3, 2013, Jeffrey has reported 18 open-market purchases worth $1.4M and 3 sales worth $2.3M on SEC Form 4. In the last 12 months: 2 sales ($1.7M).
Their filings also include grants and awards (30 filings), option exercises (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.